Retinal Diseases: The Next Frontier in Pharmacodelivery

Area of Science:

• Ophthalmology
• Pharmaceutics
• Biomedical Engineering

Background:

• Global aging population increases retinal disease prevalence.
• Retinal barriers challenge effective drug delivery.
• Existing treatments for blindness face limitations.

Purpose of the Study:

• Review unmet medical needs in retinal disease treatment.
• Discuss novel drug delivery modes and technologies.
• Explore innovations and the future of retinal pharmacodelivery.

Main Methods:

• Literature review of current and emerging retinal drug delivery systems.
• Analysis of technological advancements and their potential.
• Discussion of challenges to clinical implementation.

Main Results:

• Identified unmet needs in treating major retinal diseases.
• Highlighted novel delivery systems: implants, angiogenesis inhibitors, micro/nanocarriers, port delivery systems.
• Emphasized the potential of new pharmacodelivery frontiers.

Conclusions:

• New drug delivery technologies offer promising tools against retinal diseases.
• Clinical adoption faces medical, economic, and regulatory challenges.
• Further research and development are essential for successful market utilization.